Text Size

Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT00498082
First received: July 6, 2007
Last updated: September 5, 2007
Last verified: September 2007
History of Changes
  Purpose

EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.

The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.


Condition
Gastroesophageal Reflux Disease

Study Type: Observational
Study Design: Additional Descriptors: Convenience Sample
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Study Start Date: September 2007
Estimated Study Completion Date: September 2008
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients being considered for EsophyX treatment of GERD
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498082

Contacts
Contact: Hubert Piessevaux, MD, PhD + 32 2 764 28 34 piessevaux@gaen.ucl.ac.be

Locations
Belgium
Cliniques universitaires St-Luc Recruiting
Brussels, Belgium, 1200
Principal Investigator: Hubert Piessevaux, MD, PhD            
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: Hubert Piessevaux, MD, PhD Cliniques universitaires St-Luc
  More Information

Additional Information:
Cliniques universitaires St-Luc  This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier: NCT00498082     History of Changes
Other Study ID Numbers: UCL-STLUC-GAS-01
Study First Received: July 6, 2007
Last Updated: September 5, 2007
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Gastroesophageal Reflux
Esophageal Motility Disorders
Deglutition Disorders
 Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 16, 2013